secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspira Women's Health Inc. (AWHL)
CIK:        0000926617
Form:       8-K
Filed at:   2023-06-02T23:59:59+00:00
Accession:  0000926617-23-000052
Event type: leadership
Sentiment:  positive
Materiality: 0.55
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aspira appoints director, new CFO; regains Nasdaq bid price compliance
----------------------------------------------------------------------

- Dr. Winfred Parnell appointed to board effective June 1, 2023; also named to Nominating & Governance Committee.
- Interim CFO Marlene McLennan's term ended May 31, 2023; Dr. Torsten Hombeck to assume CFO role June 15, 2023.
- Regained Nasdaq compliance: closing bid price >=$1 for 10 consecutive days through May 25, 2023; matter closed.
- Previously disclosed deficiency in June 2022; extension granted until May 29, 2023 was met.
- Board determined Parnell meets Nasdaq independence standards.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/926617/000092661723000052/0000926617-23-000052-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/926617/000092661723000052/awh-20230526x8k.htm
  HTML page:      https://secwatch.observer/filing/0000926617-23-000052

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer